| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9824 |
| Human Intestinal Absorption | HIA+ | 0.9960 |
| Caco-2 Permeability | Caco2+ | 0.8531 |
| P-glycoprotein Substrate | Non-substrate | 0.6705 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9460 |
| Non-inhibitor | 0.9706 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7970 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7716 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8101 |
| CYP450 2D6 Substrate | Non-substrate | 0.8661 |
| CYP450 3A4 Substrate | Non-substrate | 0.5871 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6306 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9111 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9346 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8275 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9707 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8725 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9524 |
| Non-inhibitor | 0.9489 |
| AMES Toxicity | Non AMES toxic | 0.9512 |
| Carcinogens | Non-carcinogens | 0.6649 |
| Fish Toxicity | High FHMT | 0.9316 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9969 |
| Honey Bee Toxicity | High HBT | 0.7062 |
| Biodegradation | Ready biodegradable | 0.8942 |
| Acute Oral Toxicity | IV | 0.5347 |
| Carcinogenicity (Three-class) | Non-required | 0.5915 |